Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 15;36(6):751-759.
doi: 10.7507/1002-1892.202201040.

[Effect of M2-like macrophage/microglia-derived mitochondria transplantation in treatment of mouse spinal cord injury]

[Article in Chinese]
Affiliations

[Effect of M2-like macrophage/microglia-derived mitochondria transplantation in treatment of mouse spinal cord injury]

[Article in Chinese]
Tengli Huang et al. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. .

Abstract

Objective: To investigate the effect of M2-like macrophage/microglia-derived mitochondria transplantation in treatment of mouse spinal cord injury (SCI).

Methods: BV2 cells were classified into M1 (LPS treatment), M2 (IL-4 treatment), and M0 (no treatment) groups. After receiving M1 and M2 polarization, BV2 cells received microscopic observation, immunofluorescence staining [Arginase-1 (Arg-1)] and flow cytometry [inducible nitric oxide synthase (iNOS), Arg-1] to determine the result of polarization. MitoSox Red and 2, 7-dichlorodi-hydrofluorescein diacetate (DCFH-DA) stainings were used to evaluate mitochondrial function difference. Mitochondria was isolated from M2-like BV2 cells through differential velocity centrifugation for following transplantation. Then Western blot was used to measure the expression levels of the relevant complexes (complexes Ⅱ, Ⅲ, Ⅳ, and Ⅴ) in the oxidative phosphorylation (OXPHOS), and compared with M2-like BV2 cells to evaluate whether the mitochondria were obtained. Thirty-six female C57BL/6 mice were randomly divided into 3 groups ( n=12). Mice from sham group were only received the T 10 laminectomy. After the T 10 spinal cord injury (SCI) model was prepared in the SCI group and mitochondria transplantation (MT) group, mitochondrial storage solution and mitochondria (100 μg) derived from M2-like BV2 cells were injected into the injured segment, respectively. After operation, the Basso Mouse Scale (BMS) score was performed to evaluate the motor function recovery. And immunofluorescence staining, lycopersicon esculentum agglutinin (LEA)-FITC staining, and ELISA [vascular endothelial growth factor A (VEGFA)] were also performed.

Results: After polarization induction, BV2 cells in M1 and M2 groups showed specific morphological changes of M1-like and M2-like macrophages, respectively. Immunofluorescence staining showed that the positive expression of M2-like macrophages marker (Arg-1) was significantly higher in M2 group than in M0 group and M1 group ( P<0.05). Flow cytometry showed that the expression of M1-like macrophage marker (iNOS) was significantly higher in M1 group than in M0 group and M2 group ( P<0.05), and the expression of Arg-1 was significantly higher in M2 group than in M0 group and M1 group ( P<0.05). MitoSox Red and DCFH-DA stainings showed that the fluorescence intensity of the M2 group was significantly lower than that of the M1 group ( P<0.05), and there was no significant difference with the M0 group ( P>0.05). The M2-like BV2 cells-derived mitochondria was identified through Western blot assay. Animal experiments showed that the BMS scores of MT group at 21 and 28 days after operation were significantly higher than those of SCI group ( P<0.05). At 14 days after operation, the number of iNOS-positive cells in MT group was significantly lower than that in SCI group ( P<0.05), but still higher than that in sham group ( P<0.05); the number of LEA-positive cells and the expression of VEGFA in MT group were significantly more than those in the other two groups ( P<0.05).

Conclusion: M2-like macrophage/microglia-derived mitochondria transplantation can promote angiogenesis and inhibit inflammatory M1-like macrophage/microglia polarization after mouse SCI to improve function recovery.

目的: 探讨M2型巨噬细胞/小胶质细胞来源线粒体移植治疗小鼠脊髓损伤的效果。.

方法: 取小鼠小胶质细胞(BV2细胞)分别采用脂多糖(lipopolysaccharide,LPS)、IL-4诱导其向M1型(M1组)及M2型(M2组)极化,以未作任何干预的细胞作为对照(M0组);光镜下观察细胞形态,免疫荧光染色 [精氨酸酶 1(Arginase 1,Arg-1)] 及流式细胞术 [诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS)、Arg-1] 鉴定极化后细胞类型,并通过MitoSox Red与DCFH-DA染色评估细胞线粒体功能。使用差速离心法提取M2组BV2细胞来源线粒体,Western blot法测量氧化磷酸酶链(oxidative phosphorylation,OXPHOS)内各相关复合物(复合物Ⅱ、Ⅲ、Ⅳ与Ⅴ)的表达水平,并与M2型BV2细胞比较,以评估是否获得所需线粒体。取36只雌性C57BL/6小鼠随机分为3组( n=12),其中假手术组仅切除T 10椎板,脊髓损伤组及线粒体移植组制备T 10脊髓损伤模型后,于损伤节段分别注射线粒体储存液及M2型BV2细胞来源线粒体(100 μg)。术后采用BMS(Basso Mouse Scale)评分评价小鼠后肢运动功能,取材行免疫荧光染色(iNOS)、LEA-FITC染色及ELISA检测(VEGFA)。.

结果: 极化诱导后,M1组及M2组BV2细胞分别呈现M1型及M2型巨噬细胞特异性形态改变;免疫荧光染色示M2组的M2型巨噬细胞标志物Arg-1染色阳性表达高于M0组及M1组( P<0.05);流式细胞术检测示M1组的M1型巨噬细胞标志物iNOS表达高于M0组及M2组( P<0.05),M2组Arg-1表达高于M0及M1组( P<0.05)。MitoSox Red及DCFH-DA染色示M2组荧光强度均低于M1组( P<0.05),与M0组差异无统计学意义( P>0.05)。Western blot法鉴定成功提取M2型BV2细胞来源线粒体。动物实验示,线粒体移植组术后21、28 d BMS评分高于脊髓损伤组( P<0.05);术后14 d损伤局部iNOS阳性细胞数低于脊髓损伤组( P<0.05),但仍高于假手术组( P<0.05); LEA阳性细胞较其余两组增多;VEGFA表达亦高于其余两组( P<0.05)。.

结论: M2型巨噬细胞/小胶质细胞来源线粒体可通过促进损伤局部血管新生并抑制炎症性M1型巨噬细胞极化,促进小鼠脊髓损伤修复。.

Keywords: Spinal cord injury; angiogenesis; macrophage; mice; microglia; mitochondria transplantation.

PubMed Disclaimer

Conflict of interest statement

利益冲突 在课题研究和文章撰写过程中不存在利益冲突;经费支持没有影响文章观点和对研究数据客观结果的统计分析及其报道

Figures

图 1
图 1
The M2-like BV2 cells observation after polarization induction BV2细胞极化诱导后观察
图 2
图 2
Mitochondrial function of BV2 cells after polarization induction (Inverted fluorescence microscope×100) BV2细胞极化诱导后线粒体功能观察(倒置荧光显微镜×100)
图 3
图 3
Detection of OXPHOS expression in M2-like BV2 cells and their mitochondria by Western blot Western blot法检测M2型BV2细胞及其来源线粒体内OXPHOS表达
图 4
图 4
Change trend of BMS score of mice in each group after operation 术后各组小鼠BMS评分变化趋势
图 5
图 5
iNOS immunofluorescence staining of each group at 14 days after operation (Inverted fluorescence microscope×200) 术后14 d各组小鼠iNOS免疫荧光染色观察(倒置荧光显微镜×200)
图 6
图 6
LEA-FITC immunofluorescence staining of each group at 14 days after operation (Inverted fluorescence microscope×200) 术后14 d各组LEA-FITC染色观察(倒置荧光显微镜×200)

Similar articles

Cited by

References

    1. Tran AP, Warren PM, Silver J The biology of regeneration failure and success after spinal cord injury. Physiol Rev. 2018;98(2):881–917. doi: 10.1152/physrev.00017.2017. - DOI - PMC - PubMed
    1. Rabchevsky AG, Michael FM, Patel SP. Mitochondria focused neurotherapeutics for spinal cord injury. Exp Neurol, 2020, 330: 113332. doi: 10.1016/j.expneurol.2020.113332.

    1. Abbaszadeh F, Fakhri S, Khan H. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals. Pharmacol Res, 2020, 160: 105069. doi: 10.1016/j.phrs.2020.105069.

    1. Abate M, Festa A, Falco M, et al Mitochondria as playmakers of apoptosis, autophagy and senescence. Semin Cell Dev Biol. 2020;98:139–153. doi: 10.1016/j.semcdb.2019.05.022. - DOI - PubMed
    1. Simmons EC, Scholpa NE, Schnellmann RG. FDA-approved 5-HT 1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury. Exp Neurol, 2021, 341: 113720. doi: 10.1016/j.expneurol.2021.113720.

Substances